Condition: Disease/Condition Name Cancer-related Cognitive Dysfunction · Chronic Lymphocytic Leukemia (CLL) · Chronic Myeloid Leukemia, BCR-ABL1 Positive · Sponsor: University of Rochester NCORP Research Base
This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for leukemia compared to individuals who do not receive TKI therapy.
This description comes directly from the study's public registry record.
Ashley Mack, MS · 585-275-1090 · URCC_24060@urmc.rochester.edu
Always discuss trial participation with your own doctor first.
| University of Rochester NCORP Research Base | Rochester, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07638007